英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字,中文词皆可:


请选择你想看的字典辞典:
单词字典翻译
Alkermes查看 Alkermes 在百度字典中的解释百度英翻中〔查看〕
Alkermes查看 Alkermes 在Google字典中的解释Google英翻中〔查看〕
Alkermes查看 Alkermes 在Yahoo字典中的解释Yahoo英翻中〔查看〕





安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Alkermes – A Global Biopharmaceutical Company
    Alkermes plc is a fully integrated, global biopharmaceutical company developing innovative medicines in the field of neuroscience
  • Alkermes plc - Wikipedia
    Alkermes plc is a fully-integrated biopharmaceutical company that focuses on developing medicines for psychiatric and neurological disorders The company was founded in 1987 by Michael Wall [3]
  • Alkermes plc (ALKS) Stock Price, News, Quote History - Yahoo Finance
    Find the latest Alkermes plc (ALKS) stock quote, history, news and other vital information to help you with your stock trading and investing
  • Alkermes - LinkedIn
    Alkermes is a global biopharmaceutical company that seeks to develop innovative medicines in the field of neuroscience | At Alkermes, we apply our deep neuroscience expertise to develop
  • How This $4. 3 Billion Pharma Company Is Helping Underserved . . . - Forbes
    Richard Pops, CEO of Alkermes for over 30 years, transformed the company from 25 employees to a $4 3 billion valuation, focusing on neuroscience and stigmatized conditions
  • Alkermes PLC Stock Quote (U. S. : Nasdaq) - MarketWatch
    Alkermes Plc is a global biopharmaceutical company, which engages in the business of developing, manufacturing, and commercializing medicines designed to address unmet medical needs of patients
  • Alkermes HIFT | Login
    Alkermes Inc , ("Alkermes") is offering your patients the opportunity to receive free trial units of Alkermes products to facilitate prompt patient trial of the products in the inpatient hospital and crisis stabilization unit settings of care
  • Alkermes’ Lumryz, from $2. 4B Avadel buy, hits phase 3 mark in IH
    Alkermes has chalked up a quick clinical win from its $2 37 billion acquisition of Avadel, reporting Tuesday that a phase 3 study of the sodium oxybate Lumryz met all primary and key secondary
  • Alkermes may separate oncology business, says CEO
    Alkermes has said it is considering a spin-out of its cancer business into an independent, publicly-traded company, retaining its traditional focus on neurosciences The Ireland-domiciled company
  • Alkermes Medical Affairs
    The resources contained within this website may include educational resources and information relating to Alkermes, Inc medicines and therapeutic areas of interest, congress materials and publications





中文字典-英文字典  2005-2009